Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: Results of a randomized controlled trial

AIDS

Volumn 11, Issue 7, 1997, Pages 875-882

  Hawken, Mark P ^a   Meme, Hellen K ^b   Elliottc, Lyn C ^b   Chakaya, Jeremiah M ^b   Morris, Joanne S ^a   Githui, Willie A ^b   Juma, Earnest S ^b   Odhiambo, Joseph A ^b   Thiong'o, Lawrence N ^b   Kimari, Joseph N ^b   Ngugi, Elizabeth N ^b   Bwayo, Joab J ^b   Gilks, Charles F ^b   Plummer, Francis A ^b   Porter, John D H ^a   Nunn, Paul P ^a   McAdam, Keith P W J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

AIDS; HIV 1; Isoniazid chemoprophylaxis; Isoniazid preventive therapy; Tuberculosis

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; KENYA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISONIAZID; MALE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 8244223173     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199707000-00006     Document Type: Article

References (16)

1. Narain JP, Raviglione MC, Kochi A: HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tubercle Lung Dis 1992, 73:311-321.
2. Ferebee SH: Controlled chemoprophylaxis trials in tuberculosis. A general review. Adv Tubec Res 1970, 17:28-106.
3. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993, 57:183-289.
4. Daley CL, Small PM, Schecter GF, et al.: An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphism. N Engl J Med 1992, 326:231-235.
5. Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD: Effect of isoniazid prophylaxis on the incidence of active tuberculosis and progression of HIV infection. Lancet 1993, 243:268-272.
6. Wadhawan D, Hira S, Mwansa N, Perine P: Preventive tuberculosis chemotherapy with isoniazid among persons infected with HIV-1. VIII International Conference on AIDS. June 1992, Amsterdam [abstract TuB 0536].
7. Whalen C, Okwera A, Johnson J, et al.: Preventive therapy for tuberculosis in HIV-infected Ugandans. Fourth Conference on Retroviruses and Opportunistic Infection. Washington, DC, January 1997 [abstract 363].
8. British Pharmacopoeia London: HMSO; 1988, 2:957-958.
9. Aber V, Allen B, Mitchison D, Ayuma P, Edwards E, Keyes A: Quality control in tuberculosis bacteriology. Laboratory studies in isolated positive cultures and the efficacy of direct smear examination. Tubercle 1980, 61:123-133.
10. Collins C, Grange J, Yates M: Organisation and Practice in Tuberculosis Bacteriology, London: Butterworth; 1985.
11. Canetti G, Fox W, Khomenko A, et al.: Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bull WHO 1969, 41:21-43.
12. Di Perri G, Danzi M, De Checchi G, et al.: Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 1989, ii:1502-1504.
13. Edlin BR, Tokars JI, Grieco MH, et al.: An outbreak of multidrug-resistant tuberculosis among hospitalised patients with the acquired immunodeficiency syndrome. N Engl J Med 1992, 326:1514-1521.
14. Small PM, Hopewell PC, Singh BS, et al.: The epidemiology of tuberculosis in San Francisco. N Engl J Med 1994, 330:1703-1709.
15. Alland D, Kalkut GL, Moss AR, et al.: Transmission of tuberculosis in New York City. N Engl J Med 1994, 330:1710-1716.
16. Githui WA, Nunn PP, Juma E, et al.: Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results. Tubercle Lung Dis 1992, 73:203-209.